Enzalutamide is a benzamide obtained by formal condensation of the carboxy group of 4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl}-2-fluorobenzoic acid with methylamine. Used for the treatment of of metastatic castration-resistant prostate cancer. Among its listed roles, it functions as a antineoplastic agent and an androgen antagonist. It belongs to the class of benzamides, an imidazolidinone, a thiocarbonyl compound, a nitrile, a member of (trifluoromethyl)benzenes and a member of monofluorobenzenes. It is grouped under the following drug class(es): Androgen receptor inhibitors. Its therapeutic use is listed as antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include enzalutamidum and Enzalutamida. Its PubChem CID is 15951529.
Enzalutamide
| CAS No | 915087-33-1 |
|---|---|
| Molecular Formula | C21H16F4N4O2S |
| Molecular Weight | 464.4 g/mol |
| Synonyms | 4-{3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl}-2-fluoro-N-methylbenzamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Enzalutamide is a benzamide obtained by formal condensation of the carboxy group of 4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl}-2-fluorobenzoic acid with methylamine.
The listed CAS number is 915087-33-1.
The listed molecular formula is C21H16F4N4O2S.
The listed molecular weight is 464.4 g/mol.
4-{3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl}-2-fluoro-N-methylbenzamide.
The source lists enzalutamidum and Enzalutamida.